Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole PD Study in Japanese NERD Patients
NCT00259051Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2004
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of omeprazole in non-erosive reflux disease (NERD) (2 arms), sponsored by AstraZeneca. Primary endpoint: Percentage of time with intra-esophageal pH < 4 during 24 hours. Started Jan 2004; status: completed.
02
Drugs
omeprazole
03
Conditions
non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT00259051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259051.